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Abstract 
Background: Clinical improvements that follow antiretroviral therapy (ART) may lead to increase or resumption of 
high risk activities that could unintentionally result in HIV transmission. The objective was to investigate whether treat-
ment status is a significant predictor of sexual risk behaviour (unprotected sex).
Methods: A cross sectional study was conducted among 160 people living with HIV (PLHIV) (89 ART experienced 
and 71 ART naïve) attending Sukraraj Tropical and Infectious Disease Hospital in Kathmandu, Nepal. A structured 
questionnaire was used for data collection. Logistic regression with stepwise modeling was used to obtain adjusted 
odds ratios (OR) with 95 % CI.
Results: In this study, 92 % of sexually active respondents reported sex with a regular partner. ART experienced PLHIV 
were significantly more likely to report consistent condom use with their regular partners compared to ART naïve 
PLHIV (83 vs. 53 %; P = 0.006) during the past six months. In multivariate analysis, sex (OR = 4.59, 95 % CI: 1.15–18.39), 
treatment status (OR = 4.76, 95 % CI: 1.29–17.52) and alcohol consumption during last sex with regular partners 
(OR = 14.75, 95 % CI: 2.75–79.29) were significantly associated with unprotected sex.
Conclusion: ART naïve PLHIV were five times more likely to exhibit sexual risk behaviour (have unprotected sex) than 
ART experienced PLHIV. Thus the study provided no evidence to suggest that ART experienced PLHIV exhibit greater 
sexual risk behaviour compared to ART naïve PLHIV. Prevention programmes need to emphasize on counselling to 
PLHIV and their regular partners with focused interventions such as couple counselling and education programmes.
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Background
The development of antiretroviral therapy (ART) has 
led to reduction in mortality and morbidity rates among 
people living with HIV (PLHIV) [1, 2]. An early initiation 
of ART will lead to near normal quality of life and lifes-
pan [3–5]. ART reduces the concentration of the virus 
in plasma which is a primary determinant of the risk of 
transmission [6]. Reduction in risk of transmission to 
sexual partners among those initiating ART will depend 
upon viral load in plasma and genital tract [1, 7]. Even 
with the infected partner on effective ART and unde-
tectable viral loads, transmission of HIV although rare 
has been documented [8–10]. Thus, risk is substantially 
reduced [11–15] but not completely eliminated.
Clinical improvements that follow ART may lead to 
increase or resumption of high risk activities that could 
unintentionally result in HIV transmission [16]. Opti-
mism related to the success of ART in slowing disease 
progression, reducing viral load, and improving health 
status [17] might be crucial factors determining sex-
ual risk behaviours. Since highly active ART (HAART) 
became available, there has been an increase in sexual 
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risk behaviour among the PLHIV [18–22]. Beliefs about 
reduced risk for HIV transmission with ART may also 
influence the behaviour [23]. In contrast, a meta-analy-
sis did not find an increase in sexual risk behaviour fol-
lowing ART. However, it did report a higher likelihood 
of unprotected sex in individuals who believed that 
therapy prevented transmission or who were less con-
cerned about transmission given the availability of ART 
[24]. Additionally, use of ART was not associated with 
increased sexual risk behaviour in PLHIV undergoing 
ART [25, 26]; homosexual men receiving ART [27]; HIV 
infected injecting drug users [16]. Some studies suggest 
a decrease or lower sexual risk behaviour following ART 
[22, 28–30].
With increased sexual risk behaviour there is also the 
possibility of transmission of drug resistant HIV strains. 
Between 7 and 17  % of newly infected people in high 
income countries carry at least one major drug resistance 
mutation [31, 32]. On the other hand, middle and low 
income countries are estimated to have a lower preva-
lence of transmitted drug resistance at around 7 % [32]. 
This situation however is likely to change with increased 
availability of ART. Evidence from East and Southern 
Africa already show a rapid increase in transmitted drug 
resistance following ART rollout [33]. In addition to drug 
resistance, there is also the risk of superinfection, which 
is defined as an infection with a second strain follow-
ing the initial infection and immune response [34]. With 
an estimated incidence of 0–7.7  % per year, superinfec-
tions have adverse effects on clinical outcomes and might 
affect ART scale up plans [35]. Thus even with the pos-
sibility of ART for prevention, the importance of safe sex-
ual practice cannot be undermined.
In Nepal, ART was initiated in 2004 by Sukraraj Tropi-
cal and Infectious Disease Hospital, a tertiary care hos-
pital run by Government of Nepal in Teku, Kathmandu 
[36]. By the end of 2014, the government was providing 
ART free of cost to 10,407 PLHIV from 53 ART centres 
across the country [36]. According to national guidelines, 
ART is initiated when the CD4 cell count is ≤500 cells/
mm3 with priority to those with WHO clinical stage 3 or 
4 disease. It is also recommended to initiate ART in peo-
ple with active tuberculosis (TB) disease and hepatitis B 
virus co-infection with severe liver disease, all pregnant 
and breastfeeding women with HIV, and all individuals 
with HIV in serodiscordant relationships, regardless of 
CD4 cell count [37]. Those who do not fulfil these criteria 
are considered Pre ART (ART naïve) individuals who are 
regularly monitored for CD4 cell count and treated for 
opportunistic infections (OI) when necessary.
With increase in treatment coverage, greater num-
ber of people are expected to survive in Nepal, indicat-
ing an increase in prevalence of HIV infection among 
treated populations. In Nepal, it is estimated that more 
than 85 % of the total new HIV infections are the result 
of sexual transmission [38]. A small change in sexual risk 
behaviour in such population could have a large impact 
on the course of the epidemic. Studies from South Africa 
and Uganda have developed models which suggest that 
increases in sexual risk behaviour by those initiating ART 
could reduce expected declines in HIV incidence [39, 40]. 
It has been estimated that the probability for HIV epi-
demic eradication through widespread ART use is 85 % 
if sexual risk behaviour decreases [41]. If levels of risky 
sex remain stable, that probability decreases to 50 %, and 
decreases further in the presence of increased sexual risk 
behaviours [41].
Thus this study was conducted to learn more about the 
impact of ART on sexual risk behaviour. The objective 
was to investigate whether treatment status (ART expe-
rienced vs. ART naïve) is a significant predictor of sexual 
risk behaviour among PLHIV attending a tertiary care 
government hospital in Kathmandu, Nepal.
Methods
This was a cross sectional study where sexual behaviour 
of PLHIV was investigated. We collected data from the 
ART clinic of Sukraraj Tropical and Infectious Disease 
Hospital, Teku, Kathmandu, one of the tertiary care hos-
pitals in the capital city of Nepal, during July–August 
2010. This is the largest ART centre in the country where 
PLHIV are referred from various districts.
A total of 160 PLHIV (89 ART experienced and 71 ART 
naïve) were conveniently enrolled for structured inter-
views. It was assumed that the PLHIV visit the center 
in a natural random order. Every PLHIV who visited the 
center during clinic hours was considered for the study 
with enrollment based on certain criteria. The study 
included only those PLHIV who were enrolled in HIV 
care for at least six  months since HIV was diagnosed, 
who were 18 years of age or older and had not initiated 
ART (ART naïve PLHIV) or ART experienced for at 
least six  months. PLHIV who were hearing and speech 
impaired, seriously ill or admitted to hospital and those 
who could not give informed consent were not enrolled 
in the study. It was presumed that pregnancy and TB 
infection would affect the sexual behaviour of PLHIV. 
Thus they were also excluded.
PLHIV’s medical records maintained in the ART clinic 
were reviewed to record the latest CD4 cell count in 
the past six  months and date when HIV was diagnosed. 
Measure of CD4 cell count could not be obtained for all 
respondents because medical records were not updated. 
Names and other identifying information were not 
obtained. Interviews were conducted using a structured 
questionnaire to collect behavioral information. The 
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questionnaire (Additional file 1) was adapted from stand-
ardized questions used in integrated biological and behav-
ioral surveillance (IBBS) surveys in Nepal with established 
validity and reliability [42]. It was then discussed among 
experts for further validation. The questionnaire was pre-
tested among 10 % (16) of the anticipated sample size at 
the study site itself. During pre-testing, respondents hesi-
tated to answer the question on whether they had penile-
anal sex with men or women. The concept was detested 
and considered unnatural. Thus the definition of sex was 
limited to penile vaginal insertive sexual events and the 
study inquired only heterosexual behavior.
The key themes of analysis for sexual risk behaviour 
were type of partners (regular, commercial and casual 
partners), knowledge of partner’s HIV status, disclo-
sure of own HIV status to partners, alcohol consump-
tion during last sex with partners, condom use during 
last sex and consistent condom use with partners. The 
recall reference period was six months. Sex was defined 
as penile vaginal insertive sexual events during the past 
six months. A person reporting to be involved in sex with 
one or more sexual partners during the past six months 
was defined as sexually active. A commercial partner 
was defined as a partner to whom the respondent paid in 
cash or kind in exchange for sex. A regular partner was 
defined as a spouse or someone with whom the respond-
ent had a stable relationship such as boyfriend/girlfriend 
or live-in sexual partner who was never paid for sex. A 
casual partner was defined as a sexual partner with 
whom the respondent had sex only once or rarely, was 
not living with or married to and never paid (in cash or 
kind) for sex. Unprotected sex was defined as no condom 
use at last sex or inconsistent (sometimes or never) con-
dom use during sex with regular partners during the past 
six months.
The process of data management started at the study 
site with review of the completed questionnaire for 
possible errors. Data were entered in SPSS (ver.17) and 
analyzed using SPSS (ver.17) and Stata (ver.12). Before 
analysis, the data were checked and rechecked for miss-
ing values by analyzing frequencies. Fisher’s exact test 
was used to determine statistically significant differ-
ences for categorical variables. Logistic regression analy-
sis was performed to examine the effects of independent 
variables on sexual behaviour with regular partners. The 
outcome variable sexual behaviour was coded as 0 = pro-
tected sex and 1  =  unprotected sex. Initially, independ-
ent variables were included in the model one at a time to 
examine their univariate relationship with sexual behav-
iour. This was followed by the development of a mul-
tivariate model. Using an empty model to begin with, 
variables were fitted one at a time (stepwise modeling). 
At each stage, the least significant variable was excluded 
until the model contained only statistically significant 
factors. A P-value of <0.05 was considered to be statisti-
cally significant.
The study protocol was reviewed and approved by the 
Ethical Review Board of the Faculty of Health Sciences, 
Nobel College, Pokhara University and Sukraraj Tropi-
cal and Infectious Disease Hospital, Teku. The respond-
ents were given complete and clear information about 
the study being conducted enabling them to make an 
informed decision whether or not to participate in the 
study. The informed consent was obtained verbally from 
all respondents.
Results
The mean age of the respondents was 34.5  years 
(SD  =  ±6.62). Other background characteristics of 
respondents are presented in Table  1. Majority of the 
respondents were Hindus (70 %), married or living with 
a partner (63 %) currently employed (80 %), having sec-
ondary level education (42  %) and earning monthly 
income in the range of Nepalese rupees (NRs.) 5000–
10,000 (53 %) (1US Dollar = NRs. 105, as of September 
2015 [43]). Among those employed, most were engaged 
in agriculture (23  %) followed by business (19  %) (not 
shown in table). The mean time since HIV diagnosed was 
41  months (SD  =  ±3.2) and the mean CD4 cell count 
in the past six  months (n  =  146) was 242 cells/mm3 
(SD = ±13.1) (Not shown in table).
Fifty-two percent (83/160) of respondents reported 
having had sexual intercourse during the past six months 
(ART experienced  =  51  % and ART naïve  =  53  %). 
Ninety-two percent (76/83) of sexually active respond-
ents reported sex with a regular partner (ART experi-
enced = 93 % and ART naïve = 89 %) (Table 2). A greater 
number of ART experienced PLHIV reported consist-
ent condom use with their regular partner compared to 
ART naïve PLHIV (83 vs. 53  %; P =  0.006). ART expe-
rienced PLHIV reported greater condom use at last sex 
with their regular partner than ART naïve PLHIV (84 vs. 
66 %) but the difference was not statistically significant. 
Nearly 83 % of ART experienced and 71 % of ART naïve 
PLHIV knew their regular partner’s HIV status. Likewise, 
88 % of ART experienced and 85 % of ART naïve PLHIV 
disclosed their own HIV status to their regular partner. A 
majority of the ART experienced (83 %) and ART naïve 
(82  %) PLHIV did not consume alcohol during last sex 
with regular partner. Compared to ART experienced 
PLHIV a greater number of ART naïve PLHIV believed 
that ART can prevent the transmission of HIV (44 vs. 
61 %; P = 0.040).
Regarding the decision to use/not use condom during 
last sex with regular partners, a majority (61  %) of the 
males reported that they themselves took the decision to 
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use/not use condom. However in the case of females, a 
majority (80 %) reported that their male partner or both 
took the decision to use/not use condom and only 20 % 
of them reported that they themselves took the deci-
sion (not shown in table). This difference was significant 
(P = 0.004).
In univariate analysis, two variables were significantly 
associated with unprotected sex (Table  3). However 
in the final logistic regression model, three variables 
were significantly associated with unprotected sex: sex 
(OR  =  4.59, 95  % CI: 1.15–18.39), treatment status 
(OR = 4.76, 95 % CI: 1.29–17.52) and alcohol consump-
tion during last sex with regular partners (OR =  14.75, 
95 % CI: 2.75–79.29). Sex was not significant in univari-
ate analyses but was found to be significant in multivari-
ate analysis.
Discussion
Rapid development in the field of ART has led to reduc-
tion in morbidity and mortality among PLHIV. However, 
there is a growing concern over sexual risk behaviour of 
PLHIV on ART. The changes in sexual risk behaviour of 
PLHIV with the initiation of ART might have important 
implications on the way counseling may be designed and 
implemented. An increase in sexual risk behaviour with 
therapy will be a matter of great concern from a preven-
tion of transmission perspective. If not intervened, it may 
further fuel the epidemic.
In this study, only around half of the respondents 
reported to be sexually active in the past six months. It 
is possible that lower sexual activity may be a result of 
symptomatic disease or a result of adverse effects of ART 
[23]. The psychological trauma resulting from a posi-
tive diagnosis might also reduce sexual desire. A major-
ity of the respondents in both groups (ART experienced 
and ART naïve) had sex only with their regular partners 
in the past six  months. Those who had other types of 
partners always used condoms during sex except for one 
male ART naïve PLHIV who never used condom with his 
casual partner. This meant that sexual risk behaviour was 
mostly dependent upon the respondents’ condom use 
with their regular partners. This is similar to other studies 
where most reported sex was with regular partners [17, 
30, 44]. In India, 96 % of those who were sexually active 
in the past six months reported sex with a regular partner 
[17]. However, we should consider the influence of both 
recall and social desirability bias on responses related to 
sexual behaviour when interpreting these results.
In regular partner relationship, non-disclosure of self ’s 
HIV status, lack of knowledge of partner’s HIV status in 
combination with unprotected sex lays out favourable 
circumstances for transmission of HIV to serodiscord-
ant partners. Furthermore unprotected sex with regu-
lar partner also carries the risk of unwanted pregnancy 
and the transmission of HIV virus to the child. Nearly a 
fifth (20 %) of the respondents who had sex with regular 
partners were in a discordant relationship with an HIV 
negative partner but a majority of them (93 %) had pro-
tected sex. Likewise, 58 % were in a concordant relation-
ship with an HIV positive partner but a relatively lower 
percentage (66  %) reported protected sex. Unprotected 
sex with HIV positive partners carries the risk of becom-
ing infected with resistant viral strains or reinfection with 
novel strains [30].
With regular partners, ART experienced PLHIV were 
more likely to have protected sex compared to ART naïve 
PLHIV, which was similar to other studies conducted in 
a developing country setting [17, 25, 30]. Thus, the study 
provides no evidence to suggest that sexual risk behav-
iour may actually increase with initiation of ART in this 
Table 1 Socio demographic characteristics of the respond-
ents
a Janajati are considered as indigenous population groups who are specifically 
resided in local areas in various parts of country; whereas Brahmins/Chhetries 
are considered as upper class ethnic groups and have relatively more access to 
resources, power and identity [54]
b 1US$ = 105 Nepali rupees
Variables (N = 160) n (%)
Sex, female 58 (36.3)
Current residence, inside Kathmandu valley 81 (50.6)
Religion
 Hindu 107 (66.9)
 Buddhist 21 (13.1)
 Christian 26 (16.2)
 Islam 6 (3.8)
Ethnicitya
 Brahmin/Chhetri 73 (45.6)
 Janajati 68 (42.5)
 Others 19 (11.9)
Marital status
 Married or living with a partner 101 (63.1)
 Unmarried/single 20 (12.5)
 Divorced/separated 12 (7.5)
 Widow/widower 27 (16.9)
Education status
 No education 48 (30.0)
 Primary (1–5) 26 (16.2)
 Secondary (6–10) 67 (41.9)
 Higher 19 (11.9)
Unemployed 32 (20.0)
Monthly income in Nepali rupeesb (n = 98)
 <5000 28 (28.6)
 5000–10,000 52 (53.1)
 >10000 18 (18.3)
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context [23, 25, 26, 28–30]. Belief about the reduced 
severity and threat of the disease due to the availability 
of HAART as well as those about HAART related HIV 
transmission might have contributed to increased sexual 
risk behaviour [24] particularly among ART naïve PLHIV 
compared to ART experienced PLHIV. On the other 
hand, lower risk behaviour among ART experienced 
may be explained when taking into account their larger 
mean time since HIV diagnosis (43  months) compared 
to ART naïve PLHIV (29  months). This means a longer 
time had elapsed since getting tested and diagnosed with 
greater chances of having advanced HIV disease as well. 
Consequently they may perceive the seriousness of their 
illness differently and should have had several contacts 
with health workers including counsellors who conveyed 
prevention and protection messages during the course 
of treatment. This may have contributed to lower sexual 
risk behaviour. In addition, similar to a study in India, the 
belief that condoms are needed for ART to be effective 
might have facilitated consistent condom use with regu-
lar partners [45] among ART experienced PLHIV. Among 
married couples, the desire to have children might also be 
a predictor of unprotected sex with regular partners [46] 
but it was not investigated in this study. In order to get a 
clear understanding of the underlying reasons for unpro-
tected sex, it might be necessary to investigate individual 
motives through a qualitative inquiry.
Females were more likely to have unprotected sex com-
pared to males. The decision to use/not use condom was 
taken mostly by the males. Females seem to have very lit-
tle say when it comes to deciding on condom use. This 
might have contributed to this finding. A study from 
Asia found that wealthier and highly educated married 
women were more likely to report that they can refuse 
sexual intercourse and ask their husbands to use a con-
dom [47]. Additionally the study had also found that 
women’s overall involvement in making family decisions 
empowers them to negotiate safer sex [47].
Table 2 Sexual behaviour in the previous six months and belief towards ART
a Fisher’s exact test
Variables ART experienced  
n (%)
ART Naïve  
n (%)
Pa-value
Sexually active in the past six months
 Yes (n = 83) 45 (50.6) 38 (53.5) 0.752
 No 44 (49.4) 33 (46.5)
Sex with (n = 83)
 Regular partner 42 (93.3) 34 (89.5) 0.697
 Commercial and casual partners 3 (6.7) 4 (10.5)
Condom use with regular partners
 Consistent (always) 35 (83.3) 18 (52.9) 0.006
 Inconsistent (sometimes and never) 7 (16.7) 16 (47.1)
Condom use at last sex with regular partner
 Yes 38 (84.4) 25 (65.8) 0.071
 No 7 (15.6) 13 (34.2)
Knowledge of regular partner’s HIV status
 Known 35 (83.3) 24 (70.6) 0.269
 Not known 7 (16.7) 10 (29.4)
Disclosure of HIV status to regular partner
 Yes 37 (88.1) 29 (85.3) 0.745
 No 5 (11.9) 5 (14.7)
Alcohol consumption during last sex with regular partner
 Yes 7 (16.7) 6 (17.6) 1.000
 No 35 (83.3) 28 (82.4)
Can ART prevent the transmission of HIV
 Yes/don’t know 39 (43.8) 43 (60.6) 0.040
 No 50 (56.2) 28 (39.4)
With availability of ART would it make a difference if HIV transmits from you to others
 Yes 78 (87.6) 56 (78.9) 0.195
 No/don’t know 11 (12.4) 15 (21.1)
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Alcohol consumption during last sex with regular 
partners was one of the significant predictors of unpro-
tected sex. The use of alcohol may decrease the ability 
to make rational judgements and provoke risk behav-
iours as unprotected sex. Studies conducted in different 
populations and high risk sub-groups have attempted 
to examine the relationship where a number of them 
report an association between risk behaviour and alcohol 
consumption [45, 46, 48–52]. On the contrary, a meta-
analysis to assess the relationship of alcohol use and con-
dom use did not find an association [53].
Similar to the limitations of other previous studies, 
[44] this current cross-sectional study could not derive 
causal inferences. Further, the study defined sex as penile 
vaginal insertive sexual events which meant that other 
risky sexual behaviour including penile-anal sex between 
Table 3 Predictors of unprotected sex with regular partners
a Dichotomization based on sample median
b Formal education includes primary (grade 1–5), secondary (grade 6–10), higher secondary/high school (grade 11–12), under graduate and post graduate




Univariate OR  
(95 % CI)




 Female 9 (45.0) 11 (55.0) 2.46 (0.84–7.15) 0.100 4.59 (1.15–18.39) 0.031
 Male 14 (25.0) 42 (75.0)
Marital status
 Not living with a partner 1 (50.0) 1 (50.0) 2.36 (0.14–39.5) 0.549
 Living with a partner 22 (30.0) 52 (70.0)
Education levelb
 Formal education 18 (30.5) 41 (69.5) 1.05 (0.32–3.43) 0.931
 No formal education 5 (29.4) 12 (70.6)
Occupation
 Unemployed 6 (46.2) 7 (53.8) 2.32 (0.68–7.89) 0.178
 Employed 17 (26.9) 46 (73.1)
Treatment status
 ART naïve 16 (47.1) 18 (52.9) 4.44 (1.55–12.76) 0.006 4.76 (1.29–17.52) 0.019
 ART experienced 7 (16.7) 35 (83.3)
Partner’s HIV status
 Not known 7 (41.2) 10 (58.8) 1.35 (0.43–4.27) 0.606
 HIV negative 1 (6.7) 14 (93.3) 0.14 (0.02–1.15) 0.068
 HIV positive 15 (34.1) 29 (65.9)
Disclosure of own HIV status
 No 5 (50.0) 5 (50.0) 2.67 (0.69–10.31) 0.155
 Yes 18 (27.3) 48 (72.7)
Alcohol consumption during last sex
 Yes 9 (69.2) 4 (30.8) 7.88 (2.11–29.45) 0.002 14.75 (2.75–79.29) 0.002
 No 14 (22.2) 49 (77.8)
Time since HIV was diagnoseda
 ≤24 months 14 (40.0) 21 (60.0) 2.37 (0.87–6.46) 0.091
 >24 months 9 (21.9) 32 (78.1)
CD4 Cell count (cells/mm3)a
 ≤224 12 (37.5) 20 (62.5) 2.18 (0.75–6.28) 0.151
 >224 8 (21.6) 29 (78.4)
Can ART prevent the transmission of HIV
 Yes/don’t know 14 (35.0) 26 (65.0) 1.61 (0.60–4.37) 0.345
 No 9 (25.0) 27 (75.0)
With availability of ART would it make a difference if HIV transmits from you to others
 Yes 18 (27.7) 47 (72.3) 0.46 (0.12–1.70) 0.243
 No/don’t know 5 (45.4) 6 (54.6)
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men and between men and women were not accounted 
for. In the multivariate analysis, the reduction in sam-
ple size may have resulted in wider confidence intervals. 
Thus, the conclusions may be tentative, especially with 
regards to the non-significant findings. The fact that 
sex of the person was statistically significant only in the 
multivariate analysis, once ART status was controlled 
for may indicate an interaction effect, but this could not 
be tested with the small sample size. These limitations 
should be taken into consideration when interpreting 
the results of this study. Also, since sexual behaviour was 
self-reported it may have been underestimated [28, 30, 
44]. Furthermore, it is also important to note the possi-
ble influence of social desirability on study results.
Conclusions
Treatment status was found to be a significant predictor 
of sexual risk behaviour with regular partners. ART naïve 
PLHIV were five times more likely to exhibit sexual risk 
behaviour (have unprotected sex) with regular partners 
than ART experienced PLHIV. Regular partners such 
as spouses are an important group as far as prevention 
of transmission is concerned as they are the most likely 
partners.
In addition to having targeted prevention programmes 
for high risk sub-populations, the study highlights the 
need to emphasize on counselling to PLHIV and their 
regular partners. Focused interventions such as cou-
ple counselling and education programmes are required 
to be built into the total HIV care and treatment pro-
gramme. Practicing safer sex with regular sexual partners 
and refraining from alcohol use during sex should be the 
critical messages. Additionally, programmes should focus 
on empowering women to make decisions regarding con-
dom use during sex. In the future, a longitudinal study 
with adequate sample size can provide causal inferences 
regarding the impact of ART on sexual behaviours.
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